ArticleFrontiers in oncology2024

Superior survival benefits of triple combination immunotherapy compared to standard chemotherapy as second-line treatment for advanced biliary tract cancer: a retrospective analysis.

Peipei Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.